NanoPhoria vs Ray Therapeutics
NanoPhoria vs Ray Therapeutics, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: NanoPhoria is on 23/100 and Ray Therapeutics on 53/100.
Where each one leads
NanoPhoria
Leads on none of the measures we hold for both companies.
Ray Therapeutics
- our overall score: 53/100 against 23/100
- funding raised: $243M against $83.5M
At a glance
| Measure | NanoPhoria | Ray Therapeutics |
|---|---|---|
| What it is | Developing inhalable therapies for cardiovascular diseases using a proprietary nanoparticle platform. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Healthcare, Pharmaceuticals, Medical Devices | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | Not published | 2021 |
| Headquarters | Italy | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | NanoPhoria | Ray Therapeutics |
|---|---|---|
| Total funding | $83.5M | $243M |
| Latest round | null | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | NanoPhoria | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 23/100 | 53/100 |
| Traction | 40/100 | 40/100 |
| Team | Not published | 50/100 |
| Community | 10/100 | Not published |
| Search visibility | 2/100 | 14/100 |
| Quality | 25/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | NanoPhoria | Ray Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
NanoPhoria vs Ray Therapeutics: common questions
Which is better, NanoPhoria or Ray Therapeutics?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 23/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do NanoPhoria and Ray Therapeutics compare on the numbers?
Ray Therapeutics leads on our overall score (53/100 against 23/100), funding raised ($243M against $83.5M).
Read the full NanoPhoria review and pricing or the Ray Therapeutics review and pricing. You can also browse other NanoPhoria alternatives we track.